The objective of this study was to investigate whether a respiratory care bundle, implemented through participation in the Vermont Oxford Network-sponsored Neonatal Intensive Care Quality Improvement Collaborative (NIC/Q 2005) and primarily dependent on bedside caregivers, resulted in sustained decrease in the incidence of bronchopulmonary dysplasia (BPD) in infants < 30 wk gestation.
METHODS:
A retrospective cohort study was conducted. Infants inborn between 23 wk and 29 wk + 6 d of gestation were included. Patients with congenital heart disease, significant congenital or lung anomalies, or death before intubation were excluded. Four time periods (T1–T4) were identified: T1: September 1, 2002 to August 31, 2004; T2: September 1, 2004 to August 31, 2006; T3: September 1, 2006 to August 31, 2008; T4: September 1, 2008 to August 31, 2010.
RESULTS:
A total of 1,050 infants were included in the study. BPD decreased significantly in T3 post-implementation of the respiratory bundle compared with T1 (29.9% vs 51.2%, respectively; adjusted odds ratio [aOR] = 0.06 [95% CI 0.03–0.13], P = < .001). The decrease was not sustained into T4. There was a significant increase in the rate of BPD-free survival to discharge in T3 compared with T1 (53.1% vs 47%; aOR = 1.68 [95% CI 1.11–2.56], P = .01) that was also not sustained. The rate of infants requiring O2 at 28 d of life decreased significantly in T3 versus T1 (40.3% vs 69.9%, respectively; aOR = 0.12 [95% CI 0.07–0.20], P = < .001). Increases in the rate of surfactant administration by 1 h of life and rate of caffeine use were observed in T4 versus T1, respectively. There was a significant decrease in median ventilator days and a significant increase in the median number of noninvasive CPAP days throughout the study period.
CONCLUSIONS:
In this study, implementation of a respiratory bundle managed primarily by nurses and respiratory therapists was successful in increasing the use of less invasive respiratory support in a consistent manner among very low birthweight infants at a single institution. However, this study and others have failed to show sustained improvement in the incidence of BPD despite sustained process change.
JobeAH. Mechanisms to explain surfactant responses. Biol Neonate, 2006; 89(4):298–302.
2.
VarugheseM, PatoleS, ShamaA, WhitehallJ. Permissive hypercapnia in neonates: the case of the good, the bad, and the ugly. Pediatr Pulmonol, 2002; 33(1):56–64.
3.
ClarkRH, GerstmannDR, JobeAH, MoffittST, SlutskyAS, YoderBA. Lung injury in neonates: causes, strategies for prevention, and long-term consequences. 2001; 139(4):478–486.
4.
PayneNR, LaCorteM, KarnaP, ChenS, FinkelsteinM, GoldsmithJP, et al. Reduction of bronchopulmonary dysplasia after participation in the Breathsavers Group of the Vermont Oxford Network Neonatal Intensive Care Quality Improvement Collaborative. Pediatrics, 2006; 118 (Suppl 2):S73-S77.
5.
BirenbaumHJ, DentryA, CirelliJ, HelouS, PaneMA, StarrK, et al. Reduction in the incidence of chronic lung disease in very low birth weight infants: results of a quality improvement process in a tertiary level neonatal intensive care unit. Pediatrics, 2009; 123(1):44–50.
TinW, MilliganDW, PennefatherP, HeyE. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed, 2001; 84(2):F106–F110.
8.
ChowLC, WrightKW, SolaA, CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics, 2003; 111(2):339–345.
9.
AndersonCG, BenitzWE, MadanA. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol, 2004; 24(3):164–168.
10.
RabiY, RabiD, YeeW. Room air resuscitation of the depressed newborn: a systematic review and meta-analysis. Resuscitation, 2007; 72(3):353–363.
SaugstadOD. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD?. Acta Paediatr, 1997; 86(12):1277–1282.
13.
DavisJM. Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr Suppl, 2002; 91(437):23–25.
14.
JobeAH, BancalariE. Bronchopulmonary dysplasia. Am J Respir Crit Care Med, 2001; 163(7):1723–1729.
15.
WrightKW, SamiD, ThompsonL, RamanathanR, JosephR, FarzavandiS. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc, 2006; 104:78–84.
16.
AskieLM, Henderson-SmartDJ, IrwigL, SimpsonJM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med, 2003; 349(10):959–967.
17.
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes. Pediatrics, 2000; 105(2):295–310.
18.
GaynonMW, StevensonDK. What can we learn from STOP-ROP and earlier studies?. Pediatrics, 2000; 105(2):420–421.
19.
HayWWJr, BellEF. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics, 2000; 105(2):424–425.
20.
SollRF, MorleyCJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev, 2000;(2):CD000510.
21.
SchmidtB, RobertsRS, DavisP, DoyleLW, BarringtonKJ, OhlssonA, et al. Caffeine therapy for apnea of prematurity. N Engl J Med, 2006; 354(20):2112–2121.
22.
HaglerDA, TraverGA. Endotracheal saline and suction catheters: sources of lower airway contamination. Am J Crit Care, 1994; 3(6):444–447.
23.
RidlingDA, MartinLD, BrattonSL. Endotracheal suctioning with or without instillation of isotonic sodium chloride solution in critically ill children. Am J Crit Care, 2003; 12(3):212–219.
24.
BeeramMR, DhanireddyR. Effects of saline instillation during tracheal suction on lung mechanics in newborn infants. J Perinatol, 1992; 12(2):120–123.
25.
KinlochD. Instillation of normal saline during endotracheal suctioning: effects on mixed venous oxygen saturation. 1999; Am J Crit Care, 8(4):231-240; quiz 241-232.
26.
ShortenDR, ByrnePJ, JonesRL. Infant responses to saline instillations and endotracheal suctioning. J Obstet Gynecol Neonatal Nursing, 1991; 20(6):464–469.
27.
BostickJ, WendelgassST. Normal saline instillation as part of the suctioning procedure: effects on PaO2 and amount of secretions. Heart Lung J Crit Care, 1987; 16(5):532–537.
28.
ShenaiJP, ChytilF, JhaveriA, StahlmanMT. Plasma vitamin A and retinol-binding protein in premature and term neonates. J Pediatr, 1981; 99(2):302–305.
29.
DarlowBA, GrahamPJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev, 2007;(4):CD000501.
30.
AmbalavananN, WuTJ, TysonJE, KennedyKA, RoaneC, CarloWA. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. J Pediatr, 2003; 142(6):656–661.
31.
TysonJE, WrightLL, OhW, KennedyKA, MeleL, EhrenkranzRA, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med, 1999; 340(25):1962–1968.
32.
CarloWA, StarkAR, WrightLL, TysonJE, PapileLA, ShankaranS, et al. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. J Pediatr, 2002; 141(3):370–374.
33.
Henderson-SmartDJ, SteerP. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev, 2001;(3):CD000140.
34.
Henderson-SmartDJ, DavisPG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database Syst Rev, 2003;(1):CD000139.
SteerP, FlenadyV, ShearmanA, CharlesB, GrayPH, Henderson-SmartD, et al. High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed, 2004; 89(6):F499–503.
37.
MathurNB, BhatiaV. Effect of stepwise reduction in minute ventilation on PaCO2 in ventilated newborns. Indian Pediatr, 2004; 41(8):779–785.
38.
DaviesMW, KecskesZB, BerringtonJ. Determining the ventilatory volumes required to ventilate low birth weight infants with respiratory distress syndrome: prediction of arterial carbon dioxide using minute volumes. Biol Neonate, 2002; 82(4):233–237.
39.
HermetoF, BottinoMN, VaillancourtK, Sant'AnnaGM. Implementation of a respiratory therapist-driven protocol for neonatal ventilation: impact on the premature population. Pediatrics, 2009; 123(5):e907–e916.
40.
RandolphAG, WypijD, VenkataramanST, HansonJH, GedeitRG, MeertKL, et al. Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial. J Am Med Assoc, 2002; 288(20):2561–2568.
41.
SchultzTR, LinRJ, WatzmanHM, DurningSM, HalesR, WoodsonA, et al. Weaning children from mechanical ventilation: a prospective randomized trial of protocol-directed versus physician-directed weaning. Respir Care, 2001; 46(8):772–782.
42.
ElyEW, MeadeMO, HaponikEF, KollefMH, CookDJ, GuyattGH, et al. Mechanical ventilator weaning protocols driven by nonphysician health-care professionals: evidence-based clinical practice guidelines. Chest, 2001; 120(6 Suppl):454S–463S.
43.
ElyEW, BakerAM, DunaganDP, BurkeHL, SmithAC, KellyPT, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med, 1996; 335(25):1864–1869.
44.
KollefMH, ShapiroSD, SilverP, St JohnRE, PrenticeD, SauerS, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med, 1997; 25(4):567–574.
45.
MarelichGP, MurinS, BattistellaF, InciardiJ, VierraT, RobyM. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia. Chest, 2000; 118(2):459–467.
46.
GirardTD, KressJP, FuchsBD, ThomasonJW, SchweickertWD, PunBT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet, 2008; 371(9607):126–134.
47.
GirardTD, ElyEW. Protocol-driven ventilator weaning: reviewing the evidence. Clin Chest Med, 2008; 29(2):241–252, v.
48.
AlyH, MilnerJD, PatelK, El-MohandesAA. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?. Pediatrics, 2004; 114(3):697–702.
49.
PayneNR, LaCorteM, SunS, KarnaP, Lewis-HunstigerM, GoldsmithJP, et al. Evaluation and development of potentially better practices to reduce bronchopulmonary dysplasia in very low birth weight infants. Pediatrics, 2006; 118Suppl 2:S65-S72.
50.
WalshM, LaptookA, KazziSN, EngleWA, YaoQ, RasmussenM, et al. A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams. Pediatrics, 2007; 119(5):876–890.
51.
HorbarJD, RogowskiJ, PlsekPE, DelmoreP, EdwardsWH, HockerJ, et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics, 2001; 107(1):14–22.
52.
BancalariE. Bronchopulmonary dysplasia: old problem, new presentation. J Pediatr (Rio J), 2006; 82(1):2–3.
53.
PierceMR, BancalariE. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol, 1995; 19(6):371–378.
OzdemirA, BrownMA, MorganWJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol, 1997; 23(4):292–306.
56.
MunshiUK, NiuJO, SiddiqMM, PartonLA. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol, 1997; 24(5):331–336.
57.
BjorklundLJ, IngimarssonJ, CurstedtT, JohnJ, RobertsonB, WernerO, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res, 1997; 42(3):348–355.
58.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, FinerNN, CarloWA, WalshMC, RichW, GantzMG, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med, 2010; 362(21):1970–1979.
59.
WalshMC, YaoQ, GettnerP, HaleE, CollinsM, HensmanA, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics, 2004; 114(5):1305–1311.
60.
WalshMC, YaoQ, HorbarJD, CarpenterJH, LeeSK, OhlssonA. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics, 2006; 118(5):e1328–1335.
61.
WaltherFJ, FindlayRD, DurandM. Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Hum Dev, 2003; 74(1):37–45.
62.
DoyleLW, DavisPG, MorleyCJ, McPheeA, CarlinJB, DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics, 2006; 117(1):75–83.
63.
CottonRB, StahlmanMT, BenderHW, GrahamTP, CattertonWZ, KovarI. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr, 1978; 93(4):647–651.
64.
BrownER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr, 1979; 95(5 Pt 2):865–866.
65.
ClymanRI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr, 1996; 128(5 Pt 1):601–607.
